• 1. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
• 2. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 3. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 4. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 5. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acid esters

Research Brief on Diethyl 2-Ethyl-2-methylmalonate-D3 (CAS: 848565-90-2) in Chemical Biology and Pharmaceutical Applications

Diethyl 2-Ethyl-2-methylmalonate-D3 (CAS: 848565-90-2) is a deuterated analog of diethyl 2-ethyl-2-methylmalonate, a compound widely used as a building block in organic synthesis and pharmaceutical research. The incorporation of deuterium atoms (D3) into this molecule enhances its utility in metabolic studies, drug development, and analytical applications. Recent studies have highlighted its significance in the synthesis of isotopically labeled compounds, which are critical for pharmacokinetic and pharmacodynamic studies, as well as for mass spectrometry-based analytical techniques.

The primary objective of recent research involving Diethyl 2-Ethyl-2-methylmalonate-D3 has been to explore its role in the synthesis of deuterated pharmaceuticals. Deuterium labeling is known to improve the metabolic stability of drug molecules, thereby extending their half-life and reducing the frequency of dosing. Researchers have employed advanced synthetic methodologies, including catalytic deuteration and multi-step organic transformations, to incorporate this compound into more complex drug candidates. These efforts are particularly relevant in the development of central nervous system (CNS) drugs and anticancer agents, where metabolic stability is a key challenge.

In a recent study published in the Journal of Medicinal Chemistry, scientists utilized Diethyl 2-Ethyl-2-methylmalonate-D3 as a precursor for the synthesis of deuterated analogs of a promising anticancer compound. The study demonstrated that the deuterated version exhibited significantly improved metabolic stability in vitro and in vivo, without compromising the compound's efficacy. This finding underscores the potential of Diethyl 2-Ethyl-2-methylmalonate-D3 as a versatile tool in drug discovery and development.

Another area of interest is the application of Diethyl 2-Ethyl-2-methylmalonate-D3 in analytical chemistry. Due to its isotopic purity and stability, this compound is increasingly used as an internal standard in liquid chromatography-mass spectrometry (LC-MS) and gas chromatography-mass spectrometry (GC-MS) analyses. Its use ensures accurate quantification of target analytes in complex biological matrices, such as plasma and urine, thereby facilitating reliable pharmacokinetic studies.

Looking ahead, the demand for Diethyl 2-Ethyl-2-methylmalonate-D3 is expected to grow, driven by the expanding field of deuterated pharmaceuticals and the need for more precise analytical tools. Future research is likely to focus on optimizing synthetic routes to enhance yield and purity, as well as exploring new applications in drug delivery and diagnostics. Collaborative efforts between academia and industry will be crucial in unlocking the full potential of this compound.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)